Skip to main content

Education, and Financial Commitment

NeoStem, a company that focuses on developing diagnostic and therapeutic uses of adult stem cells, teamed up with the Vatican's Pontifical Council for Culture to "expand research and raise awareness of adult stem cell therapies," according to a press release from NeoStem. Together, they will develop "educational programs, publications, and academic courses with an interdisciplinary approach for theological and philosophical faculties, including those of bioethics, around the world." In a statement, the Pontifical Council for Culture's Reverend Tomasz Trafny, said: "Through educational initiatives with NeoStem and sponsorship of scientific research programs involving cutting edge adult stem cell science which does not hurt human life, we come one step closer to a breakthrough that can relieve needless human suffering.' He adds that he hopes this collaboration "could lead to significant financial commitment" to support NeoSteam's technological research.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.